|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hinweise |
|
|
|
Wiss. Komitee |
|
|
|
Adressen |
|
|
|
Presse |
|
|
|
Öffnungszeiten |
|
|
|
Gesellschaften |
|
|
|
Hotelreservierung |
|
|
|
Termine |
|
|
|
Rahmenprogramm |
|
|
|
Gebühren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Online-Anmeldung
Online-Abstracts
Kontakt-Adressen
Congress Center Leipzig
zurück zum Start
Programm-Schwerpunkte-Gesellschaften
|
Symposium 19 Pneumokokken |
||
|
12.00 - 13.30 |
Vorsitz H.D. Nothdurft; München, V. Schuster; Leipzig |
|
|
Level 1 – Raum 3 |
|
|
|
04.05.2001 |
Sy 19.01 |
Streptococcus pneumoniae– die aktuelle Resistenzlage in Deutschland |
|
12.00 |
U. Schaad; Basel (CH) |
|
|
Sy 19.02 |
Das Alexander-Projekt – die weltweite Resistenzentwicklung bei Streptococcus pneumoniae |
|
|
12.30 |
P.C. Appelbaum; Hershey (USA) |
|
|
Sy 19.03 |
Aktuelle Prävention und Therapie der Pneumokokken-Infektionen |
|
|
13.00 |
R. Reinert; Aachen |
|
|
Dieses Symposium wird gesponsert und ausgerichtet von Glaxo Smith Kline Pharma |
||